|

Sonlicromanol Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Khondrion BV1

Indications

  • Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation1
  • Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)1
  • Maternally Inherited Diabetes and Deafness (MIDD)1
  • Mitochondrial Diseases1
  • Diabetes1

Boston, Massachusetts1 trial

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Massachusetts General Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.